Pulmonary disease in HIV-infected African children

S M Graham1, J B Coulter, C F Gilks

  • 1Department of Paediatrics, College of Medicine, University of Malawi. grahamst@sesahs.nsw.gov.au

Insights

Childhood HIV infection in sub-Saharan Africa leads to severe respiratory illnesses. Further research is crucial for better diagnosis and treatment of these conditions in children.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Childhood human immunodeficiency virus (HIV) infection is prevalent in sub-Saharan Africa.
  • Respiratory diseases are leading causes of illness and death in HIV-infected children in this region.
  • Limited diagnostic tools and reliance on clinical guidelines complicate management.

Purpose of the Study:

  • To review the literature on respiratory diseases in HIV-infected children in sub-Saharan Africa.
  • To highlight knowledge gaps and the need for further research.
  • To inform improved clinical management and interventions.

Main Methods:

  • Literature review of existing studies on respiratory diseases in HIV-infected children.
  • Analysis of data on common and treatable respiratory conditions.
  • Examination of the interplay between HIV, tuberculosis, and other pulmonary diseases.

Main Results:

  • Pneumocystis pneumonia is a significant cause of severe pneumonia and mortality in infants with HIV.
  • Data on the incidence and causes of bacterial pneumonia are scarce.
  • The relationship between pulmonary tuberculosis and HIV is unclear, complicated by lymphoid interstitial pneumonitis.

Conclusions:

  • There is an urgent need for more research into respiratory diseases affecting HIV-infected children in sub-Saharan Africa.
  • Improved diagnostic capabilities and evidence-based interventions are essential.
  • Addressing these pulmonary complications is critical for reducing morbidity and mortality.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...